Detection of circulating tumor DNA following neoadjuvant chemotherapy and surgery to anticipate early relapse in ER positive and HER2 negative breast cancer: Analysis from the PENELOPE-B trial | NeoGenomics Laboratories

Publication date

Fri, 06/02/2023 - 12:00

Category

Year

Subtitle

ASCO 2023

File

ASCO_2023_Detection_of__ctDNA_following_neoadjuvant_chemotherapy_and_surgery_to_anticipate_early_relapse_in_ER_positive_and_HER2_negative_breast_cancer.pdf (2.83 MB)

Division